Withings has announced the Australian availability of the newest addition to its ScanWatch range, the ScanWatch Rose Gold.
The Withings Scanwatch according to the company is the most advanced hybrid smartwatch and the first within the Australian market to be clinically validated with ECG technology.
The ScanWatch Rose Gold not only tracks your steps but also the Breathe mode feature on the hybrid smartwatch, guides you to focus on your breathing for one minute to help you refocus and relax, something that is important given the current Covid outbreak(s).
The smartwatch can also detect atrial fibrillation (a fast and irregular heartbeat) and overnight breathing disturbances, as well as measure oxygen saturation (normal levels vital for maintaining tissue health). The ScanWatch is a pleasing rose gold colour with navy and grey bands available and will be sold through JB Hi-Fi and Amazon for $499.